ArticleExperimental and therapeutic medicine2023
Almonertinib as a neoadjuvant therapy for patients with a superior pulmonary sulcus tumor with activated EGFR mutation: A case report.
Kai Kang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.